002252.SZ · 上海莱士
China A-shares · RS rating 64 · As of 2026-10-14
| Price | 4.91 CNY |
|---|---|
| 1-day change | -0.8% |
| RS rating (overall / 1M / 3M / 12M) | 64 / 75 / 74 / 29 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 25 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +12.6% |
| Distance from 52-week high | +29.1% |
| Market cap (USD) | $5.0B |